Lim S, Kim H, Choe Y, Ahn B, Kang H, Park J
Vaccine X. 2025; 22:100601.
PMID: 39759569
PMC: 11700290.
DOI: 10.1016/j.jvacx.2024.100601.
Duran-Fernandez R, Bernal-Serrano D, Garcia-Huitron J, Hutubessy R
Bull World Health Organ. 2024; 102(5):314-322F.
PMID: 38680465
PMC: 11046164.
DOI: 10.2471/BLT.23.290207.
Guttieres D, Diepvens C, Decouttere C, Vandaele N
Vaccines (Basel). 2024; 12(1).
PMID: 38250837
PMC: 10819028.
DOI: 10.3390/vaccines12010024.
Elsayed S, Bondy L, Hanage W
Clin Microbiol Rev. 2022; 35(4):e0009222.
PMID: 36374082
PMC: 9769527.
DOI: 10.1128/cmr.00092-22.
Harapan H, Ophinni Y, Megawati D, Frediansyah A, Mamada S, Salampe M
Viruses. 2022; 14(10).
PMID: 36298710
PMC: 9612348.
DOI: 10.3390/v14102155.
Universal healthcare coverage and health service delivery before and during the COVID-19 pandemic: A difference-in-difference study of childhood immunization coverage from 195 countries.
Kim S, Headley T, Tozan Y
PLoS Med. 2022; 19(8):e1004060.
PMID: 35972985
PMC: 9380914.
DOI: 10.1371/journal.pmed.1004060.
Projecting vaccine demand and impact for emerging zoonotic pathogens.
Lerch A, Ten Bosch Q, LAzou Jackson M, Bettis A, Bernuzzi M, Murphy G
BMC Med. 2022; 20(1):202.
PMID: 35705986
PMC: 9200440.
DOI: 10.1186/s12916-022-02405-1.
The importance of vaccine stockpiling to respond to epidemics and remediate global supply shortages affecting immunization: strategic challenges and risks identified by manufacturers.
Jarrett S, Pagliusi S, Park R, Wilmansyah T, Jadhav S, Santana P
Vaccine X. 2021; 9:100119.
PMID: 34934942
PMC: 8661537.
DOI: 10.1016/j.jvacx.2021.100119.
Access to antivenoms in the developing world: A multidisciplinary analysis.
Potet J, Beran D, Ray N, Alcoba G, Habib A, Iliyasu G
Toxicon X. 2021; 12:100086.
PMID: 34786555
PMC: 8578041.
DOI: 10.1016/j.toxcx.2021.100086.
MMV-db: vaccinomics and RNA-based therapeutics database for infectious hemorrhagic fever-causing mammarenaviruses.
Khan T, Khan A, Wei D
Database (Oxford). 2021; 2021.
PMID: 34679165
PMC: 8533362.
DOI: 10.1093/database/baab063.
The evolution and future of influenza pandemic preparedness.
Harrington W, Kackos C, Webby R
Exp Mol Med. 2021; 53(5):737-749.
PMID: 33953324
PMC: 8099712.
DOI: 10.1038/s12276-021-00603-0.
Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine.
Thiel N, Selwyn C, Murphy G, Simpson S, Chakrabarti A
NPJ Vaccines. 2021; 6(1):63.
PMID: 33888722
PMC: 8062661.
DOI: 10.1038/s41541-021-00325-4.
Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets.
Luczo J, Bousse T, Johnson S, Jones C, Pearce N, Neiswanger C
NPJ Vaccines. 2021; 6(1):59.
PMID: 33883559
PMC: 8060263.
DOI: 10.1038/s41541-021-00320-9.
Modelling of optimal vaccination strategies in response to a bioterrorism associated smallpox outbreak.
Costantino V, Kunasekaran M, MacIntyre C
Hum Vaccin Immunother. 2021; 17(3):738-746.
PMID: 33734944
PMC: 7993194.
DOI: 10.1080/21645515.2020.1800324.
Modelling the impact of a smallpox attack in India and influence of disease control measures.
Mohanty B, Costantino V, Narain J, Chughtai A, Das A, MacIntyre C
BMJ Open. 2020; 10(12):e038480.
PMID: 33318109
PMC: 7737064.
DOI: 10.1136/bmjopen-2020-038480.
Challenges and prospects of snake antivenom supply in sub-Saharan Africa.
Habib A, Musa B, Iliyasu G, Hamza M, Kuznik A, Chippaux J
PLoS Negl Trop Dis. 2020; 14(8):e0008374.
PMID: 32817674
PMC: 7440614.
DOI: 10.1371/journal.pntd.0008374.
Roadmap for strengthening the vaccine supply chain in emerging countries: Manufacturers' perspectives.
Jarrett S, Yang L, Pagliusi S
Vaccine X. 2020; 5:100068.
PMID: 32775997
PMC: 7394771.
DOI: 10.1016/j.jvacx.2020.100068.
Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic.
Hosangadi D, Warmbrod K, Martin E, Adalja A, Cicero A, Inglesby T
Vaccine. 2020; 38(26):4167-4169.
PMID: 32381478
PMC: 7167542.
DOI: 10.1016/j.vaccine.2020.04.037.
A new twenty-first century science for effective epidemic response.
Bedford J, Farrar J, Ihekweazu C, Kang G, Koopmans M, Nkengasong J
Nature. 2019; 575(7781):130-136.
PMID: 31695207
PMC: 7095334.
DOI: 10.1038/s41586-019-1717-y.
Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.
Fernandez K, Lingani C, Aderinola O, Goumbi K, Bicaba B, Edea Z
J Infect Dis. 2019; 220(220 Suppl 4):S225-S232.
PMID: 31671449
PMC: 6822966.
DOI: 10.1093/infdis/jiz355.